{"entity":{"type":"insider","cik":"0001337801","url":"/insider/0001337801","json_url":"/insider/0001337801.json","name":"Scott Randal W.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":169,"n_filings":80,"first":"2007-02-14","last":"2026-05-19","span_basis":"filed_date"},"name_variants":[{"name":"Scott Randal W.","source":"filing","n_filings":11,"first_seen":"2021-02-18","last_seen":"2026-05-19"},{"name":"Scott Randal W","source":"filing","n_filings":69,"first_seen":"2007-02-14","last_seen":"2019-08-27"}],"transactions":[{"id":5765543,"accession":"0001470831-26-000470","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001470831-26-000470","line_url":"/filing/0001470831-26-000470","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W.","owner_display_name":"Scott Randal W.","owner_url":"/insider/0001337801","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":67.14556312,"price_display":"67.15","price_state":"stated","total_value":671455.6312,"total_display":"671,455.63","total_whole":"671,456","shares_owned_after":15389.0,"shares_owned_after_display":"15,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-19","scope":"insider","n_lines":4},{"id":5946738,"accession":"0001470831-26-000182","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001470831-26-000182","line_url":"/filing/0001470831-26-000182","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W.","owner_display_name":"Scott Randal W.","owner_url":"/insider/0001337801","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":75.45565952,"price_display":"75.46","price_state":"stated","total_value":754556.5952,"total_display":"754,556.60","total_whole":"754,557","shares_owned_after":14896.0,"shares_owned_after_display":"14,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-18","scope":"insider","n_lines":3},{"id":4256746,"accession":"0001470831-25-000355","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001470831-25-000355","line_url":"/filing/0001470831-25-000355","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W.","owner_display_name":"Scott Randal W.","owner_url":"/insider/0001337801","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":66.64650973,"price_display":"66.65","price_state":"stated","total_value":666465.0973,"total_display":"666,465.10","total_whole":"666,465","shares_owned_after":11589.0,"shares_owned_after_display":"11,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-19","scope":"insider","n_lines":2},{"id":3074234,"accession":"0000950170-24-069401","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-069401","line_url":"/filing/0000950170-24-069401#line-3","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W.","owner_display_name":"Scott Randal W.","owner_url":"/insider/0001337801","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":31.3,"price_display":"31.30","price_state":"stated","total_value":46950.0,"total_display":"46,950.00","total_whole":"46,950","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-05","scope":"insider"},{"id":3074230,"accession":"0000950170-24-069401","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-069401","line_url":"/filing/0000950170-24-069401","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W.","owner_display_name":"Scott Randal W.","owner_url":"/insider/0001337801","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":28.84252,"price_display":"28.84","price_state":"stated","total_value":28842.52,"total_display":"28,842.52","total_whole":"28,843","shares_owned_after":5700.0,"shares_owned_after_display":"5,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider","n_lines":2},{"id":2543633,"accession":"0000950170-24-025839","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-025839","line_url":"/filing/0000950170-24-025839#line-1","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W.","owner_display_name":"Scott Randal W.","owner_url":"/insider/0001337801","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":34.0,"price_display":"34.00","price_state":"stated","total_value":85000.0,"total_display":"85,000.00","total_whole":"85,000","shares_owned_after":6500.0,"shares_owned_after_display":"6,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-05","scope":"insider"},{"id":8000358,"accession":"0001209191-23-059324","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-059324","line_url":"/filing/0001209191-23-059324#line-1","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W.","owner_display_name":"Scott Randal W.","owner_url":"/insider/0001337801","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":80000.0,"total_display":"80,000.00","total_whole":"80,000","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-18","filed_date":"2023-12-20","scope":"insider"},{"id":8658806,"accession":"0001209191-23-057374","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-057374","line_url":"/filing/0001209191-23-057374","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W.","owner_display_name":"Scott Randal W.","owner_url":"/insider/0001337801","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":29.4,"price_display":"29.40","price_state":"stated","total_value":73500.0,"total_display":"73,500.00","total_whole":"73,500","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-01","filed_date":"2023-12-05","scope":"insider","n_lines":2},{"id":7999345,"accession":"0001209191-23-048595","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-048595","line_url":"/filing/0001209191-23-048595#line-1","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W.","owner_display_name":"Scott Randal W.","owner_url":"/insider/0001337801","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":13500.0,"shares_owned_after_display":"13,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-05","filed_date":"2023-09-07","scope":"insider"},{"id":4338157,"accession":"0001209191-21-033441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-033441","line_url":"/filing/0001209191-21-033441#line-2","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"Talis Biomedical Corp","issuer_ticker":"TLIS","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W.","owner_display_name":"Scott Randal W.","owner_url":"/insider/0001337801","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11000.0,"shares_display":"11,000","price_per_share":10.11,"price_display":"10.11","price_state":"stated","total_value":111210.0,"total_display":"111,210.00","total_whole":"111,210","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-18","scope":"insider"},{"id":4338152,"accession":"0001209191-21-033441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-033441","line_url":"/filing/0001209191-21-033441#line-1","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"Talis Biomedical Corp","issuer_ticker":"TLIS","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W.","owner_display_name":"Scott Randal W.","owner_url":"/insider/0001337801","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000.0,"shares_display":"9,000","price_per_share":10.16,"price_display":"10.16","price_state":"stated","total_value":91440.0,"total_display":"91,440.00","total_whole":"91,440","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-14","filed_date":"2021-05-18","scope":"insider"},{"id":5087562,"accession":"0000899243-21-007172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-007172","line_url":"/filing/0000899243-21-007172#line-1","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W.","owner_display_name":"Scott Randal W.","owner_url":"/insider/0001337801","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16000.0,"shares_display":"16,000","price_per_share":62.5,"price_display":"62.50","price_state":"stated","total_value":1000000.0,"total_display":"1,000,000.00","total_whole":"1,000,000","shares_owned_after":21000.0,"shares_owned_after_display":"21,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-18","scope":"insider"},{"id":4983340,"accession":"0001209191-21-012519","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-012519","line_url":"/filing/0001209191-21-012519#line-4","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"Talis Biomedical Corp","issuer_ticker":"TLIS","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W.","owner_display_name":"Scott Randal W.","owner_url":"/insider/0001337801","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":312500.0,"shares_owned_after_display":"312,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-19","scope":"insider"},{"id":8143855,"accession":"0000899243-19-022539","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-022539","line_url":"/filing/0000899243-19-022539","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":24.58511806,"price_display":"24.59","price_state":"stated","total_value":983404.7224,"total_display":"983,404.72","total_whole":"983,405","shares_owned_after":3450669.0,"shares_owned_after_display":"3,450,669","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-26","filed_date":"2019-08-27","scope":"insider","n_lines":2},{"id":7909364,"accession":"0000899243-19-015216","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-015216","line_url":"/filing/0000899243-19-015216#line-1","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":17.6009,"price_display":"17.60","price_state":"stated","total_value":528027.0,"total_display":"528,027.00","total_whole":"528,027","shares_owned_after":3490669.0,"shares_owned_after_display":"3,490,669","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-28","filed_date":"2019-05-30","scope":"insider"},{"id":8608074,"accession":"0000899243-19-004961","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-004961","line_url":"/filing/0000899243-19-004961","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":19.09991,"price_display":"19.10","price_state":"stated","total_value":572997.3,"total_display":"572,997.30","total_whole":"572,997","shares_owned_after":3521669.0,"shares_owned_after_display":"3,521,669","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-25","filed_date":"2019-02-27","scope":"insider","n_lines":2},{"id":6593118,"accession":"0000899243-18-009049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-009049","line_url":"/filing/0000899243-18-009049#line-1","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44444.0,"shares_display":"44,444","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":199998.0,"total_display":"199,998.00","total_whole":"199,998","shares_owned_after":3550669.0,"shares_owned_after_display":"3,550,669","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-02","filed_date":"2018-04-02","scope":"insider"},{"id":2585573,"accession":"0000899243-16-034175","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-034175","line_url":"/filing/0000899243-16-034175#line-1","is_derivative":false,"issuer_cik":"0001337801","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001337801","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":66666.0,"shares_display":"66,666","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":399996.0,"total_display":"399,996.00","total_whole":"399,996","shares_owned_after":3506225.0,"shares_owned_after_display":"3,506,225","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-22","filed_date":"2016-11-22","scope":"insider"},{"id":2869499,"accession":"0001209191-12-037918","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-12-037918","line_url":"/filing/0001209191-12-037918","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (CEO, InVitae Corporation*)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, InVitae Corporation*","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":34.808944,"price_display":"34.81","price_state":"stated","total_value":522134.16,"total_display":"522,134.16","total_whole":"522,134","shares_owned_after":1185417.0,"shares_owned_after_display":"1,185,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-11","filed_date":"2012-07-12","scope":"insider","n_lines":2},{"id":2869492,"accession":"0001209191-12-037918","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-037918","line_url":"/filing/0001209191-12-037918","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (CEO, InVitae Corporation*)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, InVitae Corporation*","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":35.969101333333334,"price_display":"35.97","price_state":"stated","total_value":539536.52,"total_display":"539,536.52","total_whole":"539,537","shares_owned_after":1200317.0,"shares_owned_after_display":"1,200,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-10","filed_date":"2012-07-12","scope":"insider","n_lines":2},{"id":3554878,"accession":"0001209191-12-033663","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-12-033663","line_url":"/filing/0001209191-12-033663#line-3","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (CEO, InVitae Corporation*)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, InVitae Corporation*","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":33.3103,"price_display":"33.31","price_state":"stated","total_value":499654.5,"total_display":"499,654.50","total_whole":"499,655","shares_owned_after":1215117.0,"shares_owned_after_display":"1,215,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-12","filed_date":"2012-06-13","scope":"insider"},{"id":3554873,"accession":"0001209191-12-033663","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-033663","line_url":"/filing/0001209191-12-033663","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (CEO, InVitae Corporation*)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, InVitae Corporation*","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":33.770784,"price_display":"33.77","price_state":"stated","total_value":506561.76,"total_display":"506,561.76","total_whole":"506,562","shares_owned_after":1230717.0,"shares_owned_after_display":"1,230,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-11","filed_date":"2012-06-13","scope":"insider","n_lines":2},{"id":3358618,"accession":"0001209191-12-027992","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-12-027992","line_url":"/filing/0001209191-12-027992","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (CEO, InVitae Corporation*)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, InVitae Corporation*","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":30.516161333333333,"price_display":"30.52","price_state":"stated","total_value":457742.42,"total_display":"457,742.42","total_whole":"457,742","shares_owned_after":1252917.0,"shares_owned_after_display":"1,252,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-11","filed_date":"2012-05-14","scope":"insider","n_lines":3},{"id":3358609,"accession":"0001209191-12-027992","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-027992","line_url":"/filing/0001209191-12-027992","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (CEO, InVitae Corporation*)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, InVitae Corporation*","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":29.932069333333335,"price_display":"29.93","price_state":"stated","total_value":448981.04,"total_display":"448,981.04","total_whole":"448,981","shares_owned_after":1260517.0,"shares_owned_after_display":"1,260,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-10","filed_date":"2012-05-14","scope":"insider","n_lines":2},{"id":3356825,"accession":"0001209191-12-022914","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-12-022914","line_url":"/filing/0001209191-12-022914#line-3","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (CEO, InVitae Corporation*)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, InVitae Corporation*","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":28.379,"price_display":"28.38","price_state":"stated","total_value":283790.0,"total_display":"283,790.00","total_whole":"283,790","shares_owned_after":1275117.0,"shares_owned_after_display":"1,275,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-04-11","filed_date":"2012-04-12","scope":"insider"},{"id":3356824,"accession":"0001209191-12-022914","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-022914","line_url":"/filing/0001209191-12-022914","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (CEO, InVitae Corporation*)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, InVitae Corporation*","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":28.8081292,"price_display":"28.81","price_state":"stated","total_value":288081.292,"total_display":"288,081.29","total_whole":"288,081","shares_owned_after":1285948.0,"shares_owned_after_display":"1,285,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-04-10","filed_date":"2012-04-12","scope":"insider","n_lines":2},{"id":3381039,"accession":"0001209191-12-018139","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-018139","line_url":"/filing/0001209191-12-018139#line-2","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (CEO, InVitae Corporation)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, InVitae Corporation","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":31.1176,"price_display":"31.12","price_state":"stated","total_value":466764.0,"total_display":"466,764.00","total_whole":"466,764","shares_owned_after":1295117.0,"shares_owned_after_display":"1,295,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-13","filed_date":"2012-03-14","scope":"insider"},{"id":3381038,"accession":"0001209191-12-018139","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-018139","line_url":"/filing/0001209191-12-018139#line-1","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (CEO, InVitae Corporation)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, InVitae Corporation","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":30.9787,"price_display":"30.98","price_state":"stated","total_value":464680.5,"total_display":"464,680.50","total_whole":"464,681","shares_owned_after":1310117.0,"shares_owned_after_display":"1,310,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-12","filed_date":"2012-03-14","scope":"insider"},{"id":9268091,"accession":"0001209191-12-010167","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-010167","line_url":"/filing/0001209191-12-010167#line-2","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":26.2495,"price_display":"26.25","price_state":"stated","total_value":262495.0,"total_display":"262,495.00","total_whole":"262,495","shares_owned_after":1325746.0,"shares_owned_after_display":"1,325,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-10","filed_date":"2012-02-14","scope":"insider"},{"id":2979317,"accession":"0001209191-12-009325","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-009325","line_url":"/filing/0001209191-12-009325#line-2","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":26.2495,"price_display":"26.25","price_state":"stated","total_value":262495.0,"total_display":"262,495.00","total_whole":"262,495","shares_owned_after":1325746.0,"shares_owned_after_display":"1,325,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-10","filed_date":"2012-02-13","scope":"insider"},{"id":9268092,"accession":"0001209191-12-010167","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-010167","line_url":"/filing/0001209191-12-010167#line-1","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":26.1029,"price_display":"26.10","price_state":"stated","total_value":261029.0,"total_display":"261,029.00","total_whole":"261,029","shares_owned_after":1335746.0,"shares_owned_after_display":"1,335,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-09","filed_date":"2012-02-14","scope":"insider"},{"id":2979309,"accession":"0001209191-12-009325","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-009325","line_url":"/filing/0001209191-12-009325#line-1","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":26.1029,"price_display":"26.10","price_state":"stated","total_value":261029.0,"total_display":"261,029.00","total_whole":"261,029","shares_owned_after":1335746.0,"shares_owned_after_display":"1,335,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-09","filed_date":"2012-02-13","scope":"insider"},{"id":2569687,"accession":"0001209191-12-003433","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-12-003433","line_url":"/filing/0001209191-12-003433#line-3","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337801","owner_name":"Scott Randal W","owner_display_name":"Scott Randal W","owner_url":"/insider/0001337801","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9900.0,"shares_display":"9,900","price_per_share":27.5544,"price_display":"27.55","price_state":"stated","total_value":272788.56,"total_display":"272,788.56","total_whole":"272,789","shares_owned_after":1341246.0,"shares_owned_after_display":"1,341,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-11","filed_date":"2012-01-12","scope":"insider"}],"collapsed":true,"next_cursor":"2012-01-11|2569687","ledger_fault":false,"count":{"value":169,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":163,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":169},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001743881","name":"BridgeBio Pharma, Inc.","url":"/issuer/0001743881","role":"Director","n_filings":9,"first_seen":"2021-02-18","last_seen":"2026-05-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001584751","name":"Talis Biomedical Corp","url":"/issuer/0001584751","role":"Director","n_filings":2,"first_seen":"2021-02-19","last_seen":"2021-05-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001501134","name":"Invitae Corp","url":"/issuer/0001501134","role":"Director, Officer (Executive Chairman), Ten percent owner","n_filings":5,"first_seen":"2016-11-22","last_seen":"2019-08-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001131324","name":"GENOMIC HEALTH INC","url":"/issuer/0001131324","role":"Director, Officer (CEO, InVitae Corporation*)","n_filings":64,"first_seen":"2007-02-14","last_seen":"2012-07-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001337801","retrieved_at":"2026-08-22T19:18:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}